Lowest Price Guaranteed
Pages
235
Last Updated
June 2026
View Count
17302
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
5. GUIDE TO OUTSOURCING
5.1. Chapter Overview
5.2. Outsourcing Biologics Research
5.3. Models of Outsourcing
5.3.1. Transactional Outsourcing Model
5.3.2. Performance / Outcome-based Business Model
5.3.3. Staff Augmentation Model
5.3.4. Phase-Dependent Outsourcing Model
5.4. Selecting an Appropriate Outsourcing Model
5.4.1. Hybrid Approach
5.5. Selecting a CRO Partner
5.5.1. Key Considerations for Outsourcing Biologics-related Operations
5.6. Role of CROs in the Drug Development Process
5.6.1. Discovery and Preclinical Research
5.6.2. Early Clinical Research
5.6.3. Clinical Research and Laboratory Services
5.7. Conclusion
6. MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Biologics Contract Research Organization: Overall Market Landscape
6.2.1. Analysis by Year of Establishment, Company Size and Location of Headquarters
6.2.2. Analysis by Scale of Operation
6.3. Preclinical Biologics Contract Research Organization
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Analysis by Type of Biologic
6.3.5. Analysis by Type of Services Offered
6.4. Clinical Biologics Contract Research Organization
6.4.1. Analysis by Year of Establishment
6.4.2. Analysis by Company Size
6.4.3. Analysis by Location of Headquarters
6.4.4. Analysis by Type of Biologics
6.4.5. Analysis by Type of Services Offered
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. Biocon (India)
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Services Portfolio
7.2.4. Future Outlook
7.3. Covance (US)
7.3.1. Company Overview
7.3.2. Service Portfolio
7.3.3. Financial Information
7.3.4. Future Outlook
7.4. ICON (Ireland)
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Service Portfolio
7.4.4. Future Outlook
7.5. Medpace (US)
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. Service Portfolio
7.5.4. Future Outlook
7.6. Pharmaron (China)
7.6.1. Company Overview
7.6.2. Services Portfolio
7.6.3. Future Outlook
7.7. PPD (US)
7.7.1. Company Overview
7.7.2. Service Portfolio
7.7.3. Financial Information
7.7.4. Future Outlook
7.8. PRA Health Sciences (US)
7.8.1. Company Overview
7.8.2. Financial Information
7.8.3. Service Portfolio
7.8.4. Future Outlook
7.9. Syneos Health (US)
7.9.1. Company Overview
7.9.2. Financial Information
7.9.3. Services Portfolio
7.9.4. Future Outlook
7.10. Vimta Labs (India)
7.10.1. Company Overview
7.10.2. Services Portfolio
7.10.3. Financial Information
7.10.4. Future Outlook
7.11. WuXi AppTec (China)
7.11.1. Company Overview
7.11.2. Financial Information
7.11.3. Service Portfolio
7.11.4. Future Outlook
8. BENCHMARK ANALYSIS
8.1. Chapter Overview
8.2. Methodology
8.3. Benchmark Analysis: Peer Groups
8.3.1. Peer Group I
8.3.2. Peer Group II
8.3.3. Peer Group III
8.3.4. Peer Group IV
8.3.5. Peer Group V
8.3.6. Peer Group VI
8.3.7. Peer Group VII
8.3.8. Peer Group VIII
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Biologics Contract Research Organization: Recent Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership Model
9.3.2.1. Analysis by Year of Partnership and Type of Partnership Model
9.3.3. Most Active Players: Analysis by Number of Partnerships
9.3.4. Analysis by Scale of Operation
9.3.5. Analysis by Geography
9.3.5.1. Country-wise Analysis
9.3.5.2. Intercontinental and Intracontinental Agreements
10. MERGERS AND ACQUISITIONS
10.1. Chapter Overview
10.2. Merger and Acquisition Models
10.3. Biologics Contract Research Organization: Mergers and Acquisitions
10.3.1. Analysis by Year of Acquisition
10.3.2. Analysis by Type of Collaboration
10.3.3. Analysis by Geography
10.3.3.1. Continent-wise Distribution
10.3.3.2. Country-wise Distribution
10.4. Ownership Change Matrix
10.4.1. Most Active Acquirers: Analysis by Number of Acquisitions
10.5. Distribution by Key Value Drivers
10.5.1. Analysis by Key Value Drivers
10.5.2. Analysis by Key Value Drivers and Year of Acquisitions
10.6. Valuation Analysis: Acquisition Deal Multiples
11. ATTRACTIVENESS COMPETATIVENESS MATRIX
11.1. Chapter Overview
11.2. AC Matrix: Overview
11.2.1. Strong Business Segment
11.2.2. Average Business Segment
11.2.3. Weak Business Segment
11.3. Analytical Methodology
11.4. AC Matrix: Contract Research Scenario in North America
11.5. AC Matrix: Contract Research Scenario in Europe
11.6. AC Matrix: Contract Research Scenario in Asia Pacific and Middle East
12. BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Biologics Contract Research Organization Market
12.3.1. Global Biologics Contract Research Organization Market: Distribution by Types of Biologic
12.3.2. Global Biologics Contract Research Organization Market: Distribution by Therapeutic Area
12.3.3. Global Biologics Contract Research Organization Market: Distribution by Scale of Operation
12.3.4. Global Biologics Contract Research Organization Market: Distribution by End User
12.3.5. Global Biologics Contract Research Organization Market: Distribution by Geography
13. MARKET OPPORTUNITIES BASED ON TYPE OF BIOLOGIC
13.1. Chapter Overview
13.2. Key Assumptions and Methodology
13.3. Revenue Shift Analysis
13.4. Market Movement Analysis
13.5. Penetration-Growth (P-G) Matrix
13.6. Biologics Contract Research Organization Market for Vaccine: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.7. Biologics Contract Research Organization Market for Cell Therapy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.8. Biologics Contract Research Organization Market for Gene Therapy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.9. Biologics Contract Research Organization Market for Antibodies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.10. Biologics Contract Research Organization Market for Recombinant Proteins / Peptides: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.11. Biologics Contract Research Organization Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
13.12. Data Triangulation and Validation
13.12.1. Secondary Sources
13.12.2. Primary Sources
13.12.3. Statistical Modeling
14. MARKET OPPORTUNITIES BASED ON TYPE OF SCALE OF OPERATION
14.1. Chapter Overview
14.2. Key Assumptions and Methodology
14.3. Revenue Shift Analysis
14.4. Market Movement Analysis
14.5. Penetration-Growth (P-G) Matrix
14.6. Biologics Contract Research Organization Market for Discovery: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.7. Biologics Contract Research Organization Market for Preclinical: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.8. Biologics Contract Research Organization Market for Clinical: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
14.9. Data Triangulation and Validation
14.9.1. Secondary Sources
14.9.2. Primary Sources
14.9.3. Statistical Modeling
15. MARKET OPPORTUNITIES BASED ON TYPE OF THERAPEUTIC AREA
15.1. Chapter Overview
15.2. Key Assumptions and Methodology
15.3. Revenue Shift Analysis
15.4. Market Movement Analysis
15.5. Penetration-Growth (P-G) Matrix
15.6. Biologics Contract Research Organization Market for Oncological Disorders: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.7. Biologics Contract Research Organization Market for Cardiovascular Disorders: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.8. Biologics Contract Research Organization Market for Inflammatory Disorders: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.9. Biologics Contract Research Organization Market for Neurological Disorders: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.10. Biologics Contract Research Organization Market for Other Therapeutic Areas: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
15.11. Data Triangulation and Validation
15.11.1. Secondary Sources
15.11.2. Primary Sources
15.11.3. Statistical Modeling
16. MARKET OPPORTUNITIES BASED ON END USER
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Revenue Shift Analysis
16.4. Market Movement Analysis
16.5. Penetration-Growth (P-G) Matrix
16.6. Biologics Contract Research Organization Market for Small Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.7. Biologics Contract Research Organization Market for Mid-Sized Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.8. Biologics Contract Research Organization Market for Very Large / Large Companies: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)
16.9. Data Triangulation and Validation
16.9.1. Secondary Sources
16.9.2. Primary Sources
16.9.3. Statistical Modeling
17. BIOLOGICS CONTRACT RESEARCH ORGANIZATION MARKET DISTRIBUTION BY GEOGRAPHICAL REGIONS
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. Biologics Contract Research Organization Market: Distribution by Key Geographical Region, 2025 and 2035
17.3.1. Biologics Contract Research Organization Market in North America: Historical Trends and Forecasted Estimates (Till, 2035)
17.3.2. Biologics Contract Research Organization Market in Europe: Historical Trends and Forecasted Estimates (Till, 2035)
17.3.3. Biologics Contract Research Organization Market in Asia-Pacific: Historical Trends and Forecasted Estimates (Till, 2035)
17.3.4. Biologics Contract Research Organization Market in Middle East and North Africa: Historical Trends and Forecasted Estimates (Till, 2035)
17.3.5. Biologics Contract Research Organization Market in Latin America: Historical Trends and Forecasted Estimates (Till, 2035)
17.4. Data Triangulation and Validation
18. SWOT ANALYSIS
18.1. Chapter Overview
18.2. Strengths
18.3. Weaknesses
18.4. Opportunities
18.5. Threats
18.6. Comparison of SWOT Factors
19. CONCLUDING REMARKS
19.1. Chapter Overview
20. SURVEY TRANSCRIPTS
21. APPENDIX I: TABULATED DATA
22. APPENDIX II: LIST OF COMPANIES AND ORGANIZATION